Treatment of concentration risk towards central counterparties and the counterparty risk on centrally cleared derivative transactions
This dossier concerns the treatment of concentration risk towards central counterparties and counterparty risk on centrally cleared derivative transactions. The amendments address counterparty risk exposure of UCITS in derivative, repurchase and reverse repurchase transactions that are not centrally cleared through an authorised or recognised CCP, and add provisions amending Directive 2009/138/EC requiring supervisory authorities to assess and monitor undertakings' related practices.
Procedure timeline
- Committee amendments tabled5 Jul 2023
- Plenary vote — Adopted24 Apr 2024 · On the provisional agreement negotiated with the Council (the trilogue deal) — amendment 2
- Procedure completed
Plenary votes
1 roll-call votesIn plenary, Parliament usually votes in steps: first on amendments to the text (sometimes split into parts, so Members can accept one half of a sentence and reject the other), then on the text as a whole. The “main vote” is the one that adopts or rejects the text itself. Each vote below shows exactly which step it was. How voting works →
- 24 Apr 2024Main voteAdoptedOn the provisional agreement negotiated with the Council (the trilogue deal) — amendment 2Official label: Accord provisoire - Am 2 · what was voted ↗448 for120 against21 abstentions116 did not voteForAgainstAbst.
Click a group to see each Member’s position.
Vote data: HowTheyVote.eu (ODbL, attribution) / European Parliament · roll-call votes only
Official amendment documents
Connections
See these connections as a navigable graph — and walk from there to anything else.
Explore the graphMembers who amended this procedure
13 Members · by amendment countThe amendments, in full text
6 amendmentsEvery amendment as tabled — original text, proposed change and justification, with a link to the official PDF.